Skip to content
Subscribe

California bill which would mandate STD vaccine for sixth grade girls moves forward

California bill which would mandate STD vaccine for sixth grade girls moves forward
Published:

Gardasil, a controversial vaccine for the sexually transmitted HPV virus, might soon be given to minors in California without parental consent if the sweeping proposal in a new bill-- AB 499-- becomes law after a Senate vote this week and a signature from Gov. Brown.

California Democratic Assemblywoman Toni Atkins confirmed Friday that the bill had passed the state Senate Appropriations Committee by a vote of 6 to 3. Supporters expect the bill to be fast-tracked to the Senate floor for a full vote this week and believe that Governor Jerry Brown will sign it into law.

The bill is similar to one that failed in 2007, which would have mandated that all sixth grade California girls be given the Gardasil HPV vaccination. The vaccination has made many headlines recently, because of its controversial role in the administration of Texas governor and GOP presidential candidate Rick Perry.  In 2007, Perry signed an executive order mandating that all sixth grade girls in Texas submit to the controversial vaccination, which had only been approved by the FDA eight months prior. While leading the Republican field in national polls, Perry is facing strong criticism from religious conservatives and civil libertarians in the GOP for the mandate he signed in Texas.

Supporters of the vaccine say it will help protect sexually active girls from a dangerous, cancer-causing virus. Critics have multiple reasons for opposing it. Civil libertarians oppose the mandate as a violation of individual liberty and parents' rights. Some health activists say the vaccine is a racket for big pharma profits and potentially unsafe.

Religious conservatives are concerned about the moral hazard in vaccinating young children for STDs, potentially sending them the message that it is more safe now to engage in sexual activities, with or without protection. Fiscal conservatives also have a reason to oppose the bill: it's expensive. According to the Senate Appropriations Committee’s fiscal summary:

"For the 923,000 minors aged 12 through 17...  five to ten percent immunization rate for HPV, which is a three-dose series, would result in administrative costs ranging from $1.2 million to $2.5 million in total funds."

Note that's just a five to ten percent immunization rate. Critics of the bill want to know why millions of dollars should be taken from California taxpayers and given to pharmaceutical giant, Merck, in exchange for a new, potentially harmful vaccine against a sexually trasmitted disease to be administered to schoolchildren without parental consent.

It's a good question.

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

California bill which would mandate STD vaccine for sixth grade girls moves forward

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us